Nan Guan

机构：Baylor College of Medicine, Baylor School, Children's Cancer Center

发表论文 10 篇 · 总被引 235 次 · h-index 5

代表论文

• Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer (2018 · Neoplasia · 被引 87)
• MYC dysfunction modulates stemness and tumorigenesis in breast cancer (2020 · International Journal of Biological Sciences · 被引 82)
• Flagella of Tumor‐Targeting Bacteria Trigger Local Hemorrhage to Reprogram Tumor‐Associated Macrophages for Improved Antitumor Therapy (2023 · Advanced Materials · 被引 39)
• Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu (2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 18)
• Evaluating immunotherapeutic outcomes in triple-negative breast cancer with a cholesterol radiotracer in mice (2024 · JCI Insight · 被引 9)
• Ultra early lymph node metastasis is a part of immunosurveillance and inhibits DCIS progression (2026 · Zenodo (CERN European Organization for Nuclear Research))